These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12220307)

  • 21. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL
    Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
    Vaid A; Chweich H; Balk EM; Jaber BL
    ASAIO J; 2012; 58(1):51-9. PubMed ID: 22210651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure.
    Hanish SI; Stein DM; Scalea JR; Essien EO; Thurman P; Hutson WR; Bartlett ST; Barth RN; Scalea TM
    Ann Surg; 2017 Oct; 266(4):677-684. PubMed ID: 28692474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Molecular Adsorbent Recirculating System in Patients With Liver Failure: A Case Series of 44 Patients.
    Isha S; Jenkins AS; Hanson AJ; Satashia PH; Narra SA; Mundhra GD; Hasan MM; Donepudi A; Giri A; Johnson PW; Villar D; Santos C; Canabal J; Lowman P; Franco PM; Sanghavi DK
    Transplant Proc; 2023 Nov; 55(9):2126-2133. PubMed ID: 37806867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem.
    Klammt S; Stange J; Mitzner SR; Peszynski P; Peters E; Liebe S
    Liver; 2002; 22 Suppl 2():30-4. PubMed ID: 12220300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients.
    Inderbitzin D; Muggli B; Ringger A; Beldi G; Gass M; Gloor B; Uehlinger D; Regli B; Reichen J; Candinas D
    J Gastrointest Surg; 2005 Nov; 9(8):1155-61; discussion 1161-2. PubMed ID: 16269387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation.
    Lexmond WS; Van Dael CM; Scheenstra R; Goorhuis JF; Sieders E; Verkade HJ; Van Rheenen PF; Kömhoff M
    Liver Transpl; 2015 Mar; 21(3):369-80. PubMed ID: 25366362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    Gerth HU; Pohlen M; Thölking G; Pavenstädt H; Brand M; Wilms C; Hüsing-Kabar A; Görlich D; Kabar I; Schmidt HH
    PLoS One; 2017; 12(4):e0175529. PubMed ID: 28403210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS).
    Lionte C; Sorodoc L; Simionescu V
    Rom J Gastroenterol; 2005 Sep; 14(3):267-71. PubMed ID: 16200238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin dialysis without anticoagulation in high-risk patients: an observational study.
    Tan HK; Yang WS; Choong HL; Wong KS
    Artif Organs; 2012 Mar; 36(3):E83-8. PubMed ID: 21091517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute liver failure and the Molecular Adsorbents Recirculating System: early experience in a tertiary care hospital in Mexico City.
    Méndez-Sánchez N; Chávez-Tapia NC; Espinoza B; Herrera-Gomar M; Zamora-Valdés D; Uribe M
    Ann Hepatol; 2004; 3(4):164-6. PubMed ID: 15657560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
    Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
    Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome.
    Guo LM; Liu JY; Xu DZ; Li BS; Han H; Wang LH; Zhang WY; Lu LH; Guo X; Sun FX; Zhang HY; Liu XD; Zhang JP; Yao Y; He ZP; Wang MM
    Liver Int; 2003; 23 Suppl 3():16-20. PubMed ID: 12950956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure.
    Hessel FP; Bramlage P; Wasem J; Mitzner SR
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):213-20. PubMed ID: 19773666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
    Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure.
    Schaefer B; Schaefer F; Engelmann G; Meyburg J; Heckert KH; Zorn M; Schmitt CP
    Nephrol Dial Transplant; 2011 Nov; 26(11):3633-9. PubMed ID: 21421589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease.
    Rustom N; Bost M; Cour-Andlauer F; Lachaux A; Brunet AS; Boillot O; Bordet F; Valla F; Richard N; Javouhey E
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):160-4. PubMed ID: 24458219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.